ENLIBI Trademark

Trademark Overview


On Thursday, September 4, 2025, a trademark application was filed for ENLIBI with the United States Patent and Trademark Office. The USPTO has given the ENLIBI trademark a serial number of 99374409. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, February 5, 2026. This trademark is owned by Teva Pharmaceuticals International GmbH. The ENLIBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, gastro-intestinal diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.
enlibi

General Information


Serial Number99374409
Word MarkENLIBI
Filing DateThursday, September 4, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, February 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, gastro-intestinal diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 4, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJona 8645
CH

Trademark Events


Event DateEvent Description
Thursday, September 4, 2025NEW APPLICATION ENTERED
Thursday, September 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 4, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, January 20, 2026ASSIGNED TO EXAMINER
Thursday, January 22, 2026NON-FINAL ACTION WRITTEN
Thursday, January 22, 2026NON-FINAL ACTION E-MAILED
Thursday, January 22, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 4, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 4, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 4, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 4, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 4, 2026TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, February 4, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 5, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 5, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 5, 2026TEAS/EMAIL CORRESPONDENCE ENTERED